Pettee Investors Inc. Sells 40 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pettee Investors Inc. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the fourth quarter, Holdings Channel reports. The fund owned 3,547 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Pettee Investors Inc.’s holdings in UnitedHealth Group were worth $1,794,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of UNH. Wallace Capital Management Inc. increased its position in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after buying an additional 19 shares in the last quarter. Western Pacific Wealth Management LP increased its position in shares of UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after buying an additional 19 shares in the last quarter. Paragon Capital Management LLC increased its position in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after buying an additional 20 shares in the last quarter. MCF Advisors LLC increased its position in shares of UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after buying an additional 20 shares in the last quarter. Finally, Axiom Financial Strategies LLC increased its position in shares of UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after buying an additional 20 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.2 %

Shares of NYSE:UNH opened at $493.35 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $451.28 billion, a P/E ratio of 31.83, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a 50-day simple moving average of $513.78 and a 200 day simple moving average of $553.57. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on UNH shares. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.